Universal Biosensors Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 76

Employees

  • Latest Deal Type
  • PIPE

  • Latest Deal Amount
  • $3.73M

  • Investors
  • 4

Universal Biosensors General Information

Description

Universal Biosensors Inc is a biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food, and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride, and Xprecia Prime, which are medical devices; Sentia non-medical wine testing products, and Petrackr, which is a blood glucose test used in cats and dogs. It has one reportable segment: a specialist biosensors company. Geographically, the company generates the majority of its revenue from Australia and rest from Americas, Europe and other markets.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 1 Corporate Avenue
  • Rowville, Victoria 3178
  • Australia
+61 (03)
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 1 Corporate Avenue
  • Rowville, Victoria 3178
  • Australia
+61 (03)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Universal Biosensors Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. PIPE 20-Apr-2022 $3.73M Completed Generating Revenue
8. Secondary Transaction - Private 01-Dec-2013 Completed Generating Revenue
7. PIPE 25-Nov-2012 Completed Generating Revenue
6. PIPE 12-Dec-2007 Completed Generating Revenue
5. Grant Completed Generating Revenue
4. PIPE Completed Generating Revenue
3. PIPE 13-Dec-2006 Completed Generating Revenue
2. IPO 13-Dec-2006 $14.1M $17.1M Completed Generating Revenue
1. Early Stage VC (Series A) 02-Feb-2004 $3M $3M Completed Startup
To view Universal Biosensors’s complete valuation and funding history, request access »

Universal Biosensors Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Universal Biosensors Inc is a biosensor company in electrochemical cell technology to develop a diverse range of biosens
Diagnostic Equipment
Rowville, Australia
76 As of 2024

San Diego, CA
 

Depew, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Universal Biosensors Competitors (18)

One of Universal Biosensors’s 18 competitors is ACON Laboratories, a Corporate Backed or Acquired company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ACON Laboratories Corporate Backed or Acquired San Diego, CA
Reichert Formerly PE-Backed Depew, NY
Diasorin Formerly PE-Backed Saluggia, Italy
Boston Scientific Corporation Marlborough, MA
Abbott Corporation Abbot Park, IL
You’re viewing 5 of 18 competitors. Get the full list »

Universal Biosensors Patents

Universal Biosensors Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022332700-A1 Electrochemical sensors Inactive 23-Aug-2021
EP-4392183-A1 Electrochemical sensors Inactive 23-Aug-2021
EP-4392183-A4 Electrochemical sensors Inactive 23-Aug-2021
US-20240389898-A1 Electrochemical sensors Pending 23-Aug-2021
WO-2023023737-A1 Electrochemical sensors Inactive 23-Aug-2021 A61B5/14546
To view Universal Biosensors’s complete patent history, request access »

Universal Biosensors Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Universal Biosensors Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Athyrium Capital Management Asset Manager Minority
PFM Cornerstone Venture Capital Minority
Australian Commonwealth Government Commercial Ready Grant Government
Talu Ventures Venture Capital Minority
To view Universal Biosensors’s complete investors history, request access »

Universal Biosensors Investments & Acquisitions (2)

Universal Biosensors’s most recent deal was a Corporate Asset Purchase with Siemens (Certain Assets). The deal was made on 01-Jan-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Siemens (Certain Assets) 01-Jan-2019 Corporate Asset Purchase Buildings and Property
Hemostasis Reference Laboratory 16-Dec-2016 Merger/Acquisition Consulting Services (B2B)
To view Universal Biosensors’s complete investments and acquisitions history, request access »

Universal Biosensors ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Universal Biosensors’s complete esg history, request access »

Universal Biosensors FAQs

  • When was Universal Biosensors founded?

    Universal Biosensors was founded in 2001.

  • Where is Universal Biosensors headquartered?

    Universal Biosensors is headquartered in Rowville, Australia.

  • What is the size of Universal Biosensors?

    Universal Biosensors has 76 total employees.

  • What industry is Universal Biosensors in?

    Universal Biosensors’s primary industry is Diagnostic Equipment.

  • Is Universal Biosensors a private or public company?

    Universal Biosensors is a Private company.

  • What is Universal Biosensors’s current revenue?

    The current revenue for Universal Biosensors is .

  • How much funding has Universal Biosensors raised over time?

    Universal Biosensors has raised $52.1M.

  • Who are Universal Biosensors’s investors?

    Athyrium Capital Management, PFM Cornerstone, Australian Commonwealth Government Commercial Ready Grant, and Talu Ventures have invested in Universal Biosensors.

  • Who are Universal Biosensors’s competitors?

    ACON Laboratories, Reichert, Diasorin, Boston Scientific, and Abbott are some of the 18 competitors of Universal Biosensors.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process